Camp RL - Search Results

1

PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?

Barr ML, Jilaveanu LB, Camp RL, Adeniran AJ, Kluger HM, Shuch B. Barr ML, et al. Among authors: camp rl. J Clin Pathol. 2015 Jan;68(1):12-7. doi: 10.1136/jclinpath-2014-202259. Epub 2014 Oct 14. J Clin Pathol. 2015. PMID: 25315900 Free PMC article.

2

Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells.

Kluger HM, Siddiqui SF, Angeletti C, Sznol M, Kelly WK, Molinaro AM, Camp RL. Kluger HM, et al. Among authors: camp rl. Lab Invest. 2008 Sep;88(9):962-72. doi: 10.1038/labinvest.2008.65. Epub 2008 Jul 14. Lab Invest. 2008. PMID: 18626467 Free article.

3

Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.

Mehnert JM, McCarthy MM, Jilaveanu L, Flaherty KT, Aziz S, Camp RL, Rimm DL, Kluger HM. Mehnert JM, et al. Among authors: camp rl. Hum Pathol. 2010 Mar;41(3):375-84. doi: 10.1016/j.humpath.2009.08.016. Epub 2009 Dec 11. Hum Pathol. 2010. PMID: 20004943 Free PMC article.

4

CD70 expression patterns in renal cell carcinoma.

Jilaveanu LB, Sznol J, Aziz SA, Duchen D, Kluger HM, Camp RL. Jilaveanu LB, et al. Among authors: camp rl. Hum Pathol. 2012 Sep;43(9):1394-9. doi: 10.1016/j.humpath.2011.10.014. Epub 2012 Mar 7. Hum Pathol. 2012. PMID: 22401771 Free PMC article.

5

Vascularity of primary and metastatic renal cell carcinoma specimens.

Aziz SA, Sznol J, Adeniran A, Colberg JW, Camp RL, Kluger HM. Aziz SA, et al. Among authors: camp rl. J Transl Med. 2013 Jan 14;11:15. doi: 10.1186/1479-5876-11-15. J Transl Med. 2013. PMID: 23316728 Free PMC article.

6

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors.

Aziz SA, Sznol JA, Adeniran A, Parisi F, Kluger Y, Camp RL, Kluger HM. Aziz SA, et al. Among authors: camp rl. BMC Clin Pathol. 2013 Feb 1;13:3. doi: 10.1186/1472-6890-13-3. BMC Clin Pathol. 2013. PMID: 23374878 Free PMC article.

7

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma.

Giesen E, Jilaveanu LB, Parisi F, Kluger Y, Camp RL, Kluger HM. Giesen E, et al. Among authors: camp rl. Oncotarget. 2014 Jul 30;5(14):5209-17. doi: 10.18632/oncotarget.2101. Oncotarget. 2014. PMID: 24970819 Free PMC article.

8

Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens.

Baine MK, Turcu G, Zito CR, Adeniran AJ, Camp RL, Chen L, Kluger HM, Jilaveanu LB. Baine MK, et al. Among authors: camp rl. Oncotarget. 2015 Sep 22;6(28):24990-5002. doi: 10.18632/oncotarget.4572. Oncotarget. 2015. PMID: 26317902 Free PMC article.

9

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.

Jilaveanu LB, Puligandla M, Weiss SA, Wang XV, Zito C, Flaherty KT, Boeke M, Neumeister V, Camp RL, Adeniran A, Pins M, Manola J, DiPaola RS, Haas NB, Kluger HM. Jilaveanu LB, et al. Among authors: camp rl. Clin Cancer Res. 2018 Jan 1;24(1):217-223. doi: 10.1158/1078-0432.CCR-17-1555. Epub 2017 Oct 24. Clin Cancer Res. 2018. PMID: 29066509 Free PMC article. Clinical Trial.

10

Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells.

Zito CR, Jilaveanu LB, Anagnostou V, Rimm D, Bepler G, Maira SM, Hackl W, Camp R, Kluger HM, Chao HH. Zito CR, et al. PLoS One. 2012;7(2):e31331. doi: 10.1371/journal.pone.0031331. Epub 2012 Feb 15. PLoS One. 2012. PMID: 22355357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters